Neoadjuvant chemotherapy in patients undergoing colonic resection for locally advanced nonmetastatic colon cancer: A nationwide propensity score matched cohort study.
Magnus LaursenNiclas DohrnIsmail GögenürMads Falk KleinPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2022)
Neoadjuvant chemotherapy for LACC does not result in worse short-term postoperative outcomes and may increase the R0 rate as well as node-negative disease. Results on long-term benefits including survival are awaited from several ongoing randomized controlled trials.